Brasília – The Supreme Federal Court announces the creation of the National Medication Platform, a centralized system designed to standardize information used in judicial and administrative decisions on access to medicines within the SUS. The tool aims to improve transparency, support evidence-based rulings and bring greater coherence between individual requests and national health policy.

The platform will consolidate data such as regulatory status, incorporation decisions, clinical evidence, therapeutic indications, pricing information and availability of generics or biosimilars. Authorities expect the system to reduce regional disparities, enhance budget planning and mitigate the financial impact of health-related litigation.

Source: Futuro da Saúde